Haleon PLC (H6D0) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Haleon PLC (DE:H6D0) have in its pipeline
Haleon PLC DE:H6D0 is currently developing the following drugs: Stannous Fluoride Dentifrice, Stannous Fluoride And Potassium Nitrate Dentifrice, Potassium Nitrate Dentifrice, Vehicle Dentifrice, Paracetamol Odt, Alvedon Film-Coated Tablet, Panadol Film-Coated Tablet, Active Effervescent Powder, Nutrition Training And Healthy Lifestyle Coaching, Ada Liquid Filled Capsules (Test Product), Ada Caplets (Reference Product), Advil Liqui-Gels (Reference Product), Robitussin Maximum Strength Cough And Chest Congestion Dm, Robitussin Maximum Strength Nighttime Cough Dm, Emergen-C Core Super Orange Powder, Test Dentifrice, Positive Control Dentifrice, Reference Dentifrice, Voltaren Gel 1% (Diclofenac Sodium) (Us Only), Voltaren Gel 1.16% (Diclofenac Diethylammonium) (Eu Only), Voltaren Gel 2.32% (Diclofenac Diethylammonium) (Eu Only). These drug candidates are in various stages of clinical development as the company works toward FDA approval.